A client presents to the emergency department with acute abdominal pain and a provisional diagnosis of pancreatitis. The client reports nausea and vomiting from laboratory studies. Which information is most valuable in reporting the client’s status to the healthcare provider?

Choice A reason: Rebound tenderness in the right lower quadrant (McBurney’s point) is a hallmark of appendicitis, indicating peritoneal irritation from an inflamed appendix. This localized pain, elicited on palpation release, is highly specific, guiding urgent surgical evaluation to prevent rupture and peritonitis.

Choice B reason: Diffuse abdominal pain is nonspecific and occurs in various conditions, not uniquely appendicitis, which typically presents with localized right lower quadrant pain. Rebound tenderness is more diagnostic, as it directly reflects appendiceal inflammation, making it the priority finding.

Choice C reason: Decreased bowel sounds may occur in appendicitis due to ileus but are nonspecific, seen in other abdominal conditions. Rebound tenderness is more indicative, as it localizes to the appendix, confirming peritoneal irritation, critical for diagnosing acute appendicitis.

Choice D reason: Elevated blood pressure is not specific to appendicitis and may reflect pain or stress. Rebound tenderness directly indicates appendiceal inflammation, making it the most reliable finding, as it guides diagnosis and urgent intervention to prevent complications like perforation.

Choice A reason: Lactulose increases stool frequency and liquidity to excrete ammonia in hepatic encephalopathy. A reduction in liquid stools would indicate reduced effectiveness, as the medication’s cathartic effect is essential for ammonia removal. This is not the expected therapeutic response, as increased bowel movements are desired.

Choice B reason: Lactulose reduces blood ammonia levels in hepatic encephalopathy by promoting its excretion in stool, improving mental status. Ammonia accumulation causes neurological symptoms like confusion. Improved cognition and alertness are the primary therapeutic goals, making this the expected response to effective lactulose therapy.

Choice C reason: Ambulation ability is unrelated to lactulose’s mechanism in hepatic encephalopathy. While improved mental status may indirectly aid mobility, lactulose directly targets ammonia reduction, not physical function. This is not the primary therapeutic response, as the medication addresses neurological, not musculoskeletal, symptoms in this condition.

Choice D reason: Lactulose does not directly affect urine output, as it acts in the gastrointestinal tract to excrete ammonia. While hydration status may influence urine, the medication’s primary effect is on bowel movements and ammonia reduction, not renal function, making this an incorrect therapeutic expectation.